{"id":396,"date":"1997-07-01T12:06:00","date_gmt":"1997-07-01T10:06:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/1997\/das-bfarm-gibt-bekannt-aenderungen-des-zulassungsstatus-auf-der-basis-von-einzelnen-spontanberichten-juli-bis-dezember-1996"},"modified":"2022-03-17T14:08:24","modified_gmt":"2022-03-17T13:08:24","slug":"das-bfarm-gibt-bekannt-aenderungen-des-zulassungsstatus-auf-der-basis-von-einzelnen-spontanberichten-juli-bis-dezember-1996","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/1997\/das-bfarm-gibt-bekannt-aenderungen-des-zulassungsstatus-auf-der-basis-von-einzelnen-spontanberichten-juli-bis-dezember-1996","title":{"rendered":"Das BfArM gibt bekannt: \u00c4nderungen des Zulassungsstatus auf der Basis von einzelnen Spontanberichten (Juli bis Dezember 1996)"},"content":{"rendered":"<p>\u00c4nderungen des Zulassungsstatus auf der Basis von einzelnen Spontanberichten (Juli bis Dezember 1996)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00c4nderungen des Zulassungsstatus auf der Basis von einzelnen Spontanberichten (Juli bis Dezember 1996)<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[330,255,331,302,329,332,257,333,334,303,328,298,297],"class_list":["post-396","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-5-hydroxytryptamin-rezeptor-antagonisten","tag-arzneimittel","tag-azithromycin","tag-beipackzettel","tag-fluconazol","tag-flupirtin","tag-medikamente","tag-meropenem","tag-ondansetron","tag-packungsbeilage","tag-tramadol","tag-waschzettel","tag-zulassungsstatus-von-arzneimitteln"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/396","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=396"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/396\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=396"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=396"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}